| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
211 |
206 |
$194.16 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
455 |
453 |
$187.02 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
455 |
453 |
$186.42 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,525 |
1,238 |
$56.72 |
| 99442 |
|
447 |
429 |
$0.00 |
| 86480 |
|
93 |
93 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
12 |
12 |
$0.00 |
| 91300 |
|
46 |
46 |
$0.00 |
| 86703 |
|
129 |
126 |
$0.00 |
| 80061 |
Lipid panel |
756 |
753 |
$0.00 |
| 81003 |
|
40 |
40 |
$0.00 |
| 82274 |
|
14 |
14 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
221 |
211 |
$0.00 |
| 85610 |
|
12 |
12 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14 |
14 |
$0.00 |
| 99441 |
|
231 |
217 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,424 |
1,339 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
223 |
219 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
927 |
924 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
2,337 |
2,100 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
458 |
455 |
$0.00 |
| 86593 |
|
358 |
356 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
1,562 |
1,444 |
$0.00 |
| 81015 |
|
106 |
104 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17 |
16 |
$0.00 |
| 88187 |
|
237 |
235 |
$0.00 |
| 81001 |
|
29 |
28 |
$0.00 |
| 86780 |
|
288 |
286 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
14 |
$0.00 |
| 87340 |
|
63 |
62 |
$0.00 |
| 99443 |
|
44 |
41 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
12 |
12 |
$0.00 |
| 87536 |
|
72 |
72 |
$0.00 |
| 85027 |
|
13 |
12 |
$0.00 |